ID   TGM3_HUMAN              Reviewed;         693 AA.
AC   Q08188; A8K5N6; B2RCR6; D3DVX1; O95933; Q32ML9; Q32MM0;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-SEP-2009, sequence version 4.
DT   07-APR-2021, entry version 200.
DE   RecName: Full=Protein-glutamine gamma-glutamyltransferase E;
DE            EC=2.3.2.13 {ECO:0000269|PubMed:11980702, ECO:0000269|PubMed:12679341, ECO:0000269|PubMed:27866708};
DE   AltName: Full=Transglutaminase E;
DE            Short=TG(E);
DE            Short=TGE;
DE            Short=TGase E;
DE   AltName: Full=Transglutaminase-3;
DE            Short=TGase-3;
DE   Contains:
DE     RecName: Full=Protein-glutamine gamma-glutamyltransferase E 50 kDa catalytic chain;
DE   Contains:
DE     RecName: Full=Protein-glutamine gamma-glutamyltransferase E 27 kDa non-catalytic chain;
DE   Flags: Precursor;
GN   Name=TGM3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS LYS-13; ARG-562 AND ARG-654.
RC   TISSUE=Foreskin;
RX   PubMed=8099584;
RA   Kim I.-G., Gorman J.J., Park S.-C., Chung S.-I., Steinert P.M.;
RT   "The deduced sequence of the novel protransglutaminase E (TGase3) of human
RT   and mouse.";
RL   J. Biol. Chem. 268:12682-12690(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LYS-13 AND ARG-654.
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LYS-13; LEU-163; ASN-249;
RP   ARG-654 AND MET-687.
RG   NIEHS SNPs program;
RL   Submitted (NOV-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS LYS-13 AND
RP   ARG-654.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LYS-13 AND ARG-654.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-13 AND 670-684, VARIANT LYS-13, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Osteosarcoma;
RA   Bienvenut W.V., Bensaad K., Vousden K.H.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 468-479, AND PROTEOLYTIC CLEAVAGE BY CTSL.
RX   PubMed=16565075; DOI=10.1074/jbc.m600694200;
RA   Cheng T., Hitomi K., van Vlijmen-Willems I.M., de Jongh G.J., Yamamoto K.,
RA   Nishi K., Watts C., Reinheckel T., Schalkwijk J., Zeeuwen P.L.;
RT   "Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L
RT   by a reactive site that is distinct from the legumain-binding site. A novel
RT   clue for the role of cystatin M/E in epidermal cornification.";
RL   J. Biol. Chem. 281:15893-15899(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-111 AND THR-112, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   INVOLVEMENT IN UHS2, SUBCELLULAR LOCATION, AND CATALYTIC ACTIVITY.
RX   PubMed=27866708; DOI=10.1016/j.ajhg.2016.10.004;
RA   Ue Basmanav F.B., Cau L., Tafazzoli A., Mechin M.C., Wolf S., Romano M.T.,
RA   Valentin F., Wiegmann H., Huchenq A., Kandil R., Garcia Bartels N.,
RA   Kilic A., George S., Ralser D.J., Bergner S., Ferguson D.J.,
RA   Oprisoreanu A.M., Wehner M., Thiele H., Altmueller J., Nuernberg P.,
RA   Swan D., Houniet D., Buechner A., Weibel L., Wagner N., Grimalt R.,
RA   Bygum A., Serre G., Blume-Peytavi U., Sprecher E., Schoch S., Oji V.,
RA   Hamm H., Farrant P., Simon M., Betz R.C.;
RT   "Mutations in three genes encoding proteins involved in hair shaft
RT   formation cause uncombable hair syndrome.";
RL   Am. J. Hum. Genet. 99:1292-1304(2016).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 2-693 IN COMPLEX WITH CALCIUM,
RP   COFACTOR, AND CATALYTIC ACTIVITY.
RX   PubMed=11980702; DOI=10.1093/emboj/21.9.2055;
RA   Ahvazi B., Kim H.C., Kee S.H., Nemes Z., Steinert P.M.;
RT   "Three-dimensional structure of the human transglutaminase 3 enzyme:
RT   binding of calcium ions changes structure for activation.";
RL   EMBO J. 21:2055-2067(2002).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 2-693 IN COMPLEX WITH CALCIUM AND
RP   MAGNESIUM, COFACTOR, AND CATALYTIC ACTIVITY.
RX   PubMed=12679341; DOI=10.1074/jbc.m301162200;
RA   Ahvazi B., Boeshans K.M., Idler W., Baxa U., Steinert P.M.;
RT   "Roles of calcium ions in the activation and activity of the
RT   transglutaminase 3 enzyme.";
RL   J. Biol. Chem. 278:23834-23841(2003).
CC   -!- FUNCTION: Catalyzes the calcium-dependent formation of isopeptide
CC       cross-links between glutamine and lysine residues in various proteins,
CC       as well as the conjugation of polyamines to proteins. Involved in the
CC       formation of the cornified envelope (CE), a specialized component
CC       consisting of covalent cross-links of proteins beneath the plasma
CC       membrane of terminally differentiated keratinocytes. Catalyzes small
CC       proline-rich proteins (SPRR1 and SPRR2) and LOR cross-linking to form
CC       small interchain oligomers, which are further cross-linked by TGM1 onto
CC       the growing CE scaffold (By similarity). In hair follicles, involved in
CC       cross-linking structural proteins to hardening the inner root sheath.
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-glutaminyl-[protein] + L-lysyl-[protein] = [protein]-L-
CC         lysyl-N(6)-5-L-glutamyl-[protein] + NH4(+); Xref=Rhea:RHEA:54816,
CC         Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:10207, Rhea:RHEA-COMP:14005,
CC         ChEBI:CHEBI:28938, ChEBI:CHEBI:29969, ChEBI:CHEBI:30011,
CC         ChEBI:CHEBI:138370; EC=2.3.2.13; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10024, ECO:0000269|PubMed:11980702,
CC         ECO:0000269|PubMed:12679341, ECO:0000269|PubMed:27866708};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:11980702, ECO:0000269|PubMed:12679341};
CC       Note=Binds 3 Ca(2+) cations per subunit. Binds 1 Ca(2+) as a zymogen,
CC       and binds 2 more Ca(2+) cations, or other divalent metal cations, after
CC       proteolytic processing. {ECO:0000269|PubMed:11980702,
CC       ECO:0000269|PubMed:12679341};
CC   -!- SUBUNIT: Consists of two polypeptide chains, which are synthesized as a
CC       precursor form of a single polypeptide. {ECO:0000269|PubMed:11980702,
CC       ECO:0000269|PubMed:12679341}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:27866708}.
CC   -!- PTM: Activated by proteolytic processing. In vitro activation is
CC       commonly achieved by cleavage with dispase, a neutral bacterial
CC       protease. Dispase cleavage site was proposed to lie between Ser-470 and
CC       Ser-471 (PubMed:8099584) or between Pro-465 and Phe-466
CC       (PubMed:16565075). Physiological activation may be catalyzed by CTSL
CC       and, to a lesser extent, by CTSS, but not by CTSB, CTSD nor CTSV
CC       (PubMed:16565075). {ECO:0000269|PubMed:16565075,
CC       ECO:0000269|PubMed:8099584}.
CC   -!- DISEASE: Uncombable hair syndrome 2 (UHS2) [MIM:617251]: A form of
CC       uncombable hair syndrome, a condition characterized by scalp hair that
CC       is impossible to comb due to the haphazard arrangement of the hair
CC       bundles. A characteristic morphologic feature is a triangular to
CC       reniform to heart shape on cross-sections, and a groove, canal or
CC       flattening along the entire length of the hair. Most individuals are
CC       affected early in childhood and the hair takes on a spun-glass
CC       appearance with the hair becoming dry, curly, glossy, lighter in color,
CC       and progressively uncombable. The hair growth rate can range from slow
CC       to normal, and the condition improves with age.
CC       {ECO:0000269|PubMed:27866708}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the transglutaminase superfamily.
CC       Transglutaminase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/tgm3/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L10386; AAA61155.1; -; mRNA.
DR   EMBL; AK290324; BAF83013.1; -; mRNA.
DR   EMBL; AK291351; BAF84040.1; -; mRNA.
DR   EMBL; AK315236; BAG37663.1; -; mRNA.
DR   EMBL; EF102483; ABK41960.1; -; Genomic_DNA.
DR   EMBL; AL031678; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471133; EAX10601.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10602.1; -; Genomic_DNA.
DR   EMBL; BC109075; AAI09076.1; -; mRNA.
DR   EMBL; BC109076; AAI09077.1; -; mRNA.
DR   CCDS; CCDS33435.1; -.
DR   PIR; A45991; A45991.
DR   RefSeq; NP_003236.3; NM_003245.3.
DR   PDB; 1L9M; X-ray; 2.10 A; A/B=2-693.
DR   PDB; 1L9N; X-ray; 2.10 A; A/B=2-693.
DR   PDB; 1NUD; X-ray; 2.70 A; A/B=2-693.
DR   PDB; 1NUF; X-ray; 2.70 A; A=2-693.
DR   PDB; 1NUG; X-ray; 2.40 A; A/B=2-693.
DR   PDBsum; 1L9M; -.
DR   PDBsum; 1L9N; -.
DR   PDBsum; 1NUD; -.
DR   PDBsum; 1NUF; -.
DR   PDBsum; 1NUG; -.
DR   SMR; Q08188; -.
DR   BioGRID; 112911; 47.
DR   IntAct; Q08188; 24.
DR   MINT; Q08188; -.
DR   STRING; 9606.ENSP00000370867; -.
DR   BindingDB; Q08188; -.
DR   ChEMBL; CHEMBL3363; -.
DR   DrugBank; DB01864; 5'-Guanosine-Diphosphate-Monothiophosphate.
DR   DrugBank; DB03152; B-2-Octylglucoside.
DR   DrugBank; DB04315; Guanosine-5'-Diphosphate.
DR   DrugBank; DB01972; Guanosine-5'-Monophosphate.
DR   DrugBank; DB00130; L-Glutamine.
DR   iPTMnet; Q08188; -.
DR   PhosphoSitePlus; Q08188; -.
DR   BioMuta; TGM3; -.
DR   DMDM; 257051080; -.
DR   EPD; Q08188; -.
DR   jPOST; Q08188; -.
DR   MassIVE; Q08188; -.
DR   MaxQB; Q08188; -.
DR   PaxDb; Q08188; -.
DR   PeptideAtlas; Q08188; -.
DR   PRIDE; Q08188; -.
DR   ProteomicsDB; 58578; -.
DR   TopDownProteomics; Q08188; -.
DR   Antibodypedia; 1375; 310 antibodies.
DR   Ensembl; ENST00000381458; ENSP00000370867; ENSG00000125780.
DR   GeneID; 7053; -.
DR   KEGG; hsa:7053; -.
DR   UCSC; uc002wfx.5; human.
DR   CTD; 7053; -.
DR   DisGeNET; 7053; -.
DR   GeneCards; TGM3; -.
DR   HGNC; HGNC:11779; TGM3.
DR   HPA; ENSG00000125780; Group enriched (esophagus, lymphoid tissue, tongue).
DR   MalaCards; TGM3; -.
DR   MIM; 600238; gene.
DR   MIM; 617251; phenotype.
DR   neXtProt; NX_Q08188; -.
DR   OpenTargets; ENSG00000125780; -.
DR   Orphanet; 1410; Uncombable hair syndrome.
DR   PharmGKB; PA36492; -.
DR   VEuPathDB; HostDB:ENSG00000125780.11; -.
DR   eggNOG; ENOG502QUPB; Eukaryota.
DR   GeneTree; ENSGT01000000214519; -.
DR   HOGENOM; CLU_013435_1_0_1; -.
DR   InParanoid; Q08188; -.
DR   OMA; GWNFGQY; -.
DR   OrthoDB; 297055at2759; -.
DR   PhylomeDB; Q08188; -.
DR   TreeFam; TF324278; -.
DR   BRENDA; 2.3.2.13; 2681.
DR   PathwayCommons; Q08188; -.
DR   BioGRID-ORCS; 7053; 3 hits in 985 CRISPR screens.
DR   ChiTaRS; TGM3; human.
DR   EvolutionaryTrace; Q08188; -.
DR   GeneWiki; TGM3; -.
DR   GenomeRNAi; 7053; -.
DR   Pharos; Q08188; Tchem.
DR   PRO; PR:Q08188; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q08188; protein.
DR   Bgee; ENSG00000125780; Expressed in lower esophagus mucosa and 125 other tissues.
DR   Genevisible; Q08188; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0003824; F:catalytic activity; IDA:UniProtKB.
DR   GO; GO:0003810; F:protein-glutamine gamma-glutamyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; IDA:UniProtKB.
DR   GO; GO:0016746; F:transferase activity, transferring acyl groups; TAS:UniProtKB.
DR   GO; GO:0043163; P:cell envelope organization; IDA:UniProtKB.
DR   GO; GO:0006464; P:cellular protein modification process; NAS:UniProtKB.
DR   GO; GO:0031069; P:hair follicle morphogenesis; TAS:UniProtKB.
DR   GO; GO:0031424; P:keratinization; IEA:UniProtKB-KW.
DR   GO; GO:0030216; P:keratinocyte differentiation; IEP:UniProtKB.
DR   GO; GO:0018149; P:peptide cross-linking; IDA:UniProtKB.
DR   Gene3D; 2.60.40.10; -; 3.
DR   Gene3D; 3.90.260.10; -; 1.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR002931; Transglutaminase-like.
DR   InterPro; IPR036985; Transglutaminase-like_sf.
DR   InterPro; IPR023608; Transglutaminase_animal.
DR   InterPro; IPR013808; Transglutaminase_AS.
DR   InterPro; IPR008958; Transglutaminase_C.
DR   InterPro; IPR036238; Transglutaminase_C_sf.
DR   InterPro; IPR001102; Transglutaminase_N.
DR   Pfam; PF00927; Transglut_C; 2.
DR   Pfam; PF01841; Transglut_core; 1.
DR   Pfam; PF00868; Transglut_N; 1.
DR   PIRSF; PIRSF000459; TGM_EBP42; 1.
DR   SMART; SM00460; TGc; 1.
DR   SUPFAM; SSF49309; SSF49309; 2.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS00547; TRANSGLUTAMINASES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Calcium; Cytoplasm;
KW   Direct protein sequencing; Keratinization; Metal-binding; Phosphoprotein;
KW   Reference proteome; Transferase; Zymogen.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.7"
FT   CHAIN           2..467
FT                   /note="Protein-glutamine gamma-glutamyltransferase E 50 kDa
FT                   catalytic chain"
FT                   /id="PRO_0000033652"
FT   CHAIN           468..693
FT                   /note="Protein-glutamine gamma-glutamyltransferase E 27 kDa
FT                   non-catalytic chain"
FT                   /id="PRO_0000033653"
FT   ACT_SITE        273
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10024"
FT   ACT_SITE        331
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10024"
FT   ACT_SITE        354
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10024"
FT   METAL           222
FT                   /note="Calcium 1; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   METAL           225
FT                   /note="Calcium 1"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   METAL           227
FT                   /note="Calcium 1; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   METAL           228
FT                   /note="Calcium 1"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   METAL           230
FT                   /note="Calcium 1; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   METAL           302
FT                   /note="Calcium 2"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   METAL           304
FT                   /note="Calcium 2"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   METAL           306
FT                   /note="Calcium 2"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   METAL           308
FT                   /note="Calcium 2; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   METAL           325
FT                   /note="Calcium 2"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   METAL           394
FT                   /note="Calcium 3"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   METAL           416
FT                   /note="Calcium 3; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   METAL           444
FT                   /note="Calcium 3"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   METAL           449
FT                   /note="Calcium 3"
FT                   /evidence="ECO:0000269|PubMed:11980702,
FT                   ECO:0000269|PubMed:12679341"
FT   SITE            467..468
FT                   /note="Cleavage; by CTSL"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.7"
FT   MOD_RES         111
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         112
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   VARIANT         13
FT                   /note="T -> K (in dbSNP:rs214803)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:8099584,
FT                   ECO:0000269|Ref.3, ECO:0000269|Ref.5, ECO:0000269|Ref.7"
FT                   /id="VAR_040067"
FT   VARIANT         163
FT                   /note="I -> L (in dbSNP:rs6048066)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_040068"
FT   VARIANT         249
FT                   /note="S -> N (in dbSNP:rs214814)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_040069"
FT   VARIANT         562
FT                   /note="K -> R (in dbSNP:rs1042617)"
FT                   /evidence="ECO:0000269|PubMed:8099584"
FT                   /id="VAR_040070"
FT   VARIANT         654
FT                   /note="G -> R (in dbSNP:rs214830)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:8099584,
FT                   ECO:0000269|Ref.3, ECO:0000269|Ref.5"
FT                   /id="VAR_040071"
FT   VARIANT         687
FT                   /note="L -> M (in dbSNP:rs45581032)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_055360"
FT   CONFLICT        58..59
FT                   /note="VS -> DT (in Ref. 1; AAA61155)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        251
FT                   /note="N -> G (in Ref. 1; AAA61155)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        324
FT                   /note="S -> G (in Ref. 2; BAF84040)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        346
FT                   /note="S -> P (in Ref. 1; AAA61155)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        674
FT                   /note="D -> G (in Ref. 2; BAF84040)"
FT                   /evidence="ECO:0000305"
FT   STRAND          6..10
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           13..19
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          31..33
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          38..46
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          53..59
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          61..63
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   TURN            66..69
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          70..79
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          82..92
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          95..101
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          109..119
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          122..134
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           149..155
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          160..167
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          170..177
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           185..193
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           197..201
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           203..208
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           209..211
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           213..223
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   TURN            227..229
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          231..235
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           247..249
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           253..262
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          268..271
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           273..287
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          291..300
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          305..313
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   TURN            322..325
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          326..337
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   TURN            341..343
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           345..347
FT                   /evidence="ECO:0007744|PDB:1NUG"
FT   STRAND          349..353
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          356..359
FT                   /evidence="ECO:0007744|PDB:1NUD"
FT   HELIX           372..377
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   TURN            383..385
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           386..394
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          396..403
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   TURN            404..407
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          408..426
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          433..435
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           437..440
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          444..446
FT                   /evidence="ECO:0007744|PDB:1NUF"
FT   HELIX           447..460
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          482..489
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          499..507
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          509..511
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          513..524
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          530..543
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          548..555
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   HELIX           557..560
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   TURN            561..563
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          569..577
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          584..591
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          597..603
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          611..618
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          621..623
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          627..633
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   TURN            635..637
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          638..640
FT                   /evidence="ECO:0007744|PDB:1L9N"
FT   STRAND          642..646
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          654..661
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          667..677
FT                   /evidence="ECO:0007744|PDB:1L9M"
FT   STRAND          680..692
FT                   /evidence="ECO:0007744|PDB:1L9M"
SQ   SEQUENCE   693 AA;  76632 MW;  EAFAC0C9A8AA5FD6 CRC64;
     MAALGVQSIN WQTAFNRQAH HTDKFSSQEL ILRRGQNFQV LMIMNKGLGS NERLEFIVST
     GPYPSESAMT KAVFPLSNGS SGGWSAVLQA SNGNTLTISI SSPASAPIGR YTMALQIFSQ
     GGISSVKLGT FILLFNPWLN VDSVFMGNHA EREEYVQEDA GIIFVGSTNR IGMIGWNFGQ
     FEEDILSICL SILDRSLNFR RDAATDVASR NDPKYVGRVL SAMINSNDDN GVLAGNWSGT
     YTGGRDPRSW NGSVEILKNW KKSGFSPVRY GQCWVFAGTL NTALRSLGIP SRVITNFNSA
     HDTDRNLSVD VYYDPMGNPL DKGSDSVWNF HVWNEGWFVR SDLGPSYGGW QVLDATPQER
     SQGVFQCGPA SVIGVREGDV QLNFDMPFIF AEVNADRITW LYDNTTGKQW KNSVNSHTIG
     RYISTKAVGS NARMDVTDKY KYPEGSDQER QVFQKALGKL KPNTPFAATS SMGLETEEQE
     PSIIGKLKVA GMLAVGKEVN LVLLLKNLSR DTKTVTVNMT AWTIIYNGTL VHEVWKDSAT
     MSLDPEEEAE HPIKISYAQY EKYLKSDNMI RITAVCKVPD ESEVVVERDI ILDNPTLTLE
     VLNEARVRKP VNVQMLFSNP LDEPVRDCVL MVEGSGLLLG NLKIDVPTLG PKEGSRVRFD
     ILPSRSGTKQ LLADFSCNKF PAIKAMLSID VAE
//
